Variant report
Variant | nsv515734 |
---|---|
Chromosome Location | chr9:72520270-72530315 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:72480266..72482674-chr9:72527396..72529225,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MAMDC2-3 | chr9:72520870-72521143 | NONHSAT131791 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10511974 | chr9:72520270-72520271 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs552502485 | chr9:72520280-72520281 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs570422475 | chr9:72520380-72520381 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs79613235 | chr9:72520425-72520426 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs142973843 | chr9:72520441-72520442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568177621 | chr9:72520462-72520463 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536430612 | chr9:72520529-72520530 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs187255903 | chr9:72520538-72520539 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs576327451 | chr9:72520544-72520545 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs11463217 | chr9:72520556-72520557 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191240582 | chr9:72520560-72520561 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs7872485 | chr9:72520570-72520571 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs184388698 | chr9:72520571-72520572 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541441720 | chr9:72520606-72520607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12349451 | chr9:72520625-72520626 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs530253390 | chr9:72520702-72520703 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs190597407 | chr9:72520811-72520812 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs56235401 | chr9:72520823-72520824 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs41282439 | chr9:72520838-72520839 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs372619371 | chr9:72520849-72520850 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201982979 | chr9:72520860-72520861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs373412738 | chr9:72520876-72520877 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs145668801 | chr9:72520897-72520898 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs200233754 | chr9:72520906-72520907 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs375729816 | chr9:72520912-72520913 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs370945700 | chr9:72520915-72520916 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs374542595 | chr9:72520916-72520917 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs138325359 | chr9:72520928-72520929 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs141342918 | chr9:72520929-72520930 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs535221991 | chr9:72520940-72520941 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs199948115 | chr9:72520944-72520945 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs376653927 | chr9:72520955-72520956 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs199871632 | chr9:72520982-72520983 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs200967474 | chr9:72521001-72521002 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs371335484 | chr9:72521068-72521069 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs373979864 | chr9:72521079-72521080 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs368105740 | chr9:72521093-72521094 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs367769048 | chr9:72521098-72521099 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs560910200 | chr9:72521166-72521167 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs144704499 | chr9:72521172-72521173 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs577498935 | chr9:72521207-72521208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs534698585 | chr9:72521217-72521218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs553378181 | chr9:72521219-72521220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs567316254 | chr9:72521229-72521230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs574744462 | chr9:72521249-72521250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs542303156 | chr9:72521255-72521256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs536391139 | chr9:72521374-72521375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs75635282 | chr9:72521375-72521376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs185191523 | chr9:72521460-72521461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs564210127 | chr9:72521523-72521524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17133270 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Melanoma | 22183965 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Oral cancer | 21386901 | CNVD |
Epilepsy | 22083797 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Schizophrenia | 23813976 | CNVD |
Breast cancer | 22522925 | CNVD |
Intellectual disability | 21811512 | CNVD |
Autism | 21484199 | CNVD |
Breast cancer | 22737080 | CNVD |
Malignant peripheral nerve sheath tumor | 22811580 | CNVD |
Leprosy | 22719964 | CNVD |
Primary ovarian insufficiency | 22879975 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:72514000-72539600 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
2 | chr9:72515800-72520800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
3 | chr9:72519400-72521200 | Enhancers | HMEC | breast |
4 | chr9:72519800-72521200 | Enhancers | Muscle Satellite Cultured Cells | -- |
5 | chr9:72520200-72520600 | Enhancers | HSMM | muscle |
6 | chr9:72520200-72521000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr9:72520600-72535200 | Weak transcription | HSMM | muscle |
8 | chr9:72520800-72521200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
9 | chr9:72521000-72531200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr9:72526800-72528000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr9:72527400-72528000 | Enhancers | Muscle Satellite Cultured Cells | -- |
12 | chr9:72528200-72529600 | Weak transcription | Muscle Satellite Cultured Cells | -- |